<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37690503</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-7162</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>The American journal of medicine</Title><ISOAbbreviation>Am J Med</ISOAbbreviation></Journal><ArticleTitle>Physical Health and Mental Fatigue Disability Associated with Long COVID: Baseline Results from a US Nationwide Cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0002-9343(23)00540-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjmed.2023.08.009</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent symptoms after severe acute respiratory disease coronavirus 2 (SARS-COV-2; long COVID) occur in 10%-55% of individuals, but the impact on daily functioning and disability remains unquantified.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To characterize disability associated with long COVID, we analyzed baseline data from an online, US-based cohort study. Adult participants included those reporting a history of COVID-19 (n&#xa0;=&#xa0;8874) or never having COVID-19 (n&#xa0;=&#xa0;633) without prior disability. The main outcomes were self-reported physical mobility, instrumental activities of daily living (IADL), and mental fatigue disability, assessed by measuring 5 disability components: difficulty walking a quarter mile or climbing 10 stairs (mobility), difficulty doing light or heavy housework (IADL), and Wood Mental Fatigue Inventory score (mental fatigue).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 7926 participants with long COVID, 65% were classified with at least one disability, as compared with 6% and 14% for resolved COVID and no COVID, respectively. Additionally, 22% were classified as disabled in all 3 categories. Age, prior comorbidity, increased body mass index, female sex, COVID-19 hospitalization, non-white/multi-race were associated with higher disability burden. Dizziness and heavy limbs at infection were associated with disability regardless of hospitalization. Dyspnea and tremors were associated with disability in non-hospitalized individuals. Vaccination was protective against disability.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We observed a high burden of new disability associated with long COVID, which has serious implications for individual and societal health. Longitudinal evaluation of COVID-19 patients is necessary to identify patterns of recovery and treatment options.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wentz</LastName><ForeName>Eryka</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Zhanmo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yenokyan</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Candelaria</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Shruti H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggal</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. Electronic address: pduggal@jhu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AI094189</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med</MedlineTA><NlmUniqueID>0267200</NlmUniqueID><ISSNLinking>0002-9343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2022 Dec 07:2022.12.07.22283203. doi: 10.1101/2022.12.07.22283203</RefSource><PMID Version="1">36523402</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mental fatigue</Keyword><Keyword MajorTopicYN="N">Physical disability</Keyword></KeywordList><CoiStatement><b>Conflict of Interest Disclosures:</b> We have no conflicts to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>10</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37690503</ArticleId><ArticleId IdType="mid">NIHMS1940394</ArticleId><ArticleId IdType="pmc">PMC10924070</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2023.08.009</ArticleId><ArticleId IdType="pii">S0002-9343(23)00540-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paul P, El-Naas A, Hamad O, et al. Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review. Hum Vaccin Immunother. 2023;19(1):2167410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10054360</ArticleId><ArticleId IdType="pubmed">36915960</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ley PA, Zariri A, van Riet E, Oosterhoff D, Kruiswijk CP. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection. Front Immunol. 2021;12:781280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721663</ArticleId><ArticleId IdType="pubmed">34987509</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Du Z, James E, et al. The effectiveness of COVID-19 testing and contact tracing in a US city. Proc Natl Acad Sci U S A. 2022;119(34):e2200652119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9407477</ArticleId><ArticleId IdType="pubmed">35969766</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo FR, Waddell LA, Cheung AM, et al. Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review. doi:10.1101/2021.06.03.21258317</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.03.21258317</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open. 2022;5(10):e2238804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Nicolau E, Rivera A, Putrino D. Post-COVID Conditions and Burden of Disease. Phys Med Rehabil Clin N Am. 2023;34(3):499&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">37419527</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz GM, Bach K, Bobos P, et al. Understanding How Post-COVID-19 Condition Affects Adults and Health Care Systems. JAMA Health Forum. 2023;4(7):e231933.</Citation><ArticleIdList><ArticleId IdType="pubmed">37418268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021;11(1):13153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection. JAMA Network Open. 2021;4(10):e2128568. doi:10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. 2021;126(3):e110&#x2013;e113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Walle-Hansen MM, Ranhoff AH, Mellings&#xe6;ter M, Wang-Hansen MS, Myrstad M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21(1):199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7983098</ArticleId><ArticleId IdType="pubmed">33752614</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggal P, Penson T, Manley HN, et al. Post-sequelae symptoms and comorbidities after COVID-19. J Med Virol. 2022;94(5):2060&#x2013;2066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8958980</ArticleId><ArticleId IdType="pubmed">35032030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandmann FG, Tessier E, Lacy J, et al. Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls. Clin Infect Dis. 2022;75(1):e962&#x2013;e973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903473</ArticleId><ArticleId IdType="pubmed">35245941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokolevich ZM, Crowe M, Mendez D, Biros E, Reznik JE. Most Common Long COVID Physical Symptoms in Working Age Adults Who Experienced Mild COVID-19 Infection: A Scoping Review. Healthcare (Basel). 2022;10(12). doi:10.3390/healthcare10122577</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10122577</ArticleId><ArticleId IdType="pmc">PMC9778298</ArticleId><ArticleId IdType="pubmed">36554098</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Machado FVC, Meys R, et al. Care Dependency in Non-Hospitalized Patients with COVID-19. J Clin Med Res. 2020;9(9). doi:10.3390/jcm9092946</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092946</ArticleId><ArticleId IdType="pmc">PMC7564703</ArticleId><ArticleId IdType="pubmed">32932582</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Organization W. A clinical case definition of post COVID-19 condition by a Delphi consensus. Accessed November 2, 2022. https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?utm_source=yxnews&amp;utm_medium=mobile</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone JL, Norris AH. Activities and attitudes of participants in the Baltimore longitudinal study. J Gerontol. 1966;21(4):575&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">5918312</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentall RP, Wood GC, Marrinan T, Deans C, Edwards RH. A brief mental fatigue questionnaire. Br J Clin Psychol. 1993;32(3):375&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">7902751</ArticleId></ArticleIdList></Reference><Reference><Citation>Westreich D, Edwards JK, Lesko CR, Stuart E, Cole SR. Transportability of Trial Results Using Inverse Odds of Sampling Weights. Am J Epidemiol. 2017;186(8):1010&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860052</ArticleId><ArticleId IdType="pubmed">28535275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishwaran H, Lu M. Standard errors and confidence intervals for variable importance in random forest regression, classification, and survival. Stat Med. 2019;38(4):558&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6279615</ArticleId><ArticleId IdType="pubmed">29869423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter F, Barkay N, Bilinski A, et al. Partnering with a global platform to inform research and public policy making. In: Survey Research Methods. Vol 14. ; 2020:159&#x2013;163.</Citation></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahey GM, McDonald E, Marshall K, et al. Risk factors for hospitalization among persons with COVID-19-Colorado. PLoS One. 2021;16(9):e0256917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412293</ArticleId><ArticleId IdType="pubmed">34473791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Locke E, Green P, et al. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. JAMA Netw Open. 2020;3(9):e2022310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7512055</ArticleId><ArticleId IdType="pubmed">32965502</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336&#x2013;2342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756553</ArticleId><ArticleId IdType="pubmed">23753844</ArticleId></ArticleIdList></Reference><Reference><Citation>Carew S, Connor MO, Cooke J, et al. A review of postural orthostatic tachycardia syndrome. Europace. 2009;11(1):18&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">19088364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugaya N, Arai M, Goto F. Changes in cognitive function in patients with intractable dizziness following vestibular rehabilitation. Sci Rep. 2018;8(1):9984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030069</ArticleId><ArticleId IdType="pubmed">29968816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Seo JH, Lee SJ, Lee DH. Therapeutic effect of steroids on vestibular neuritis: Systematic review and meta-analysis. Clin Otolaryngol. 2022;47(1):34&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">34687143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bl&#xe4;ttler W, Thomae HJ, Amsler F. Venous leg symptoms in healthy subjects assessed during prolonged standing. J Vasc Surg Venous Lymphat Disord. 2016;4(4):455&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">27639000</ArticleId></ArticleIdList></Reference><Reference><Citation>Halperin JL. Evaluation of patients with peripheral vascular disease. Thromb Res. 2002;106(6):V303&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">12359343</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>